Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Non-cash Items (2016 - 2022)

Ovid Therapeutics filings provide 7 years of Non-cash Items readings, the most recent being $3.1 million for Q1 2022.

  • Quarterly Non-cash Items fell 52.29% to $3.1 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Mar 2022, down 52.29% year-over-year, with the annual reading at $2.4 million for FY2021, 266.3% up from the prior year.
  • Non-cash Items hit $3.1 million in Q1 2022 for Ovid Therapeutics, up from $2.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $18.2 million in Q2 2020 and bottomed at $142994.0 in Q2 2019.
  • Average Non-cash Items over 5 years is $3.9 million, with a median of $2.4 million recorded in 2019.
  • The largest annual shift saw Non-cash Items tumbled 98.12% in 2018 before it surged 12639.53% in 2020.
  • Ovid Therapeutics' Non-cash Items stood at $153485.0 in 2018, then surged by 2824.67% to $4.5 million in 2019, then plummeted by 85.47% to $652438.0 in 2020, then surged by 266.3% to $2.4 million in 2021, then rose by 28.84% to $3.1 million in 2022.
  • Per Business Quant, the three most recent readings for OVID's Non-cash Items are $3.1 million (Q1 2022), $2.4 million (Q4 2021), and $3.0 million (Q3 2021).